Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3)
Year: 2014
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Care
DOI: 10.2337/dc13-2759
Institutions: Emory University, Eli Lilly (United States)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2030546890
